UPDATE: Piper Jaffray Reiterates Overweight on MAKO Surgical, Raises PT to $36

Piper Jaffray reiterated its Overweight rating on MAKO Surgical MAKO. At the same time, the rating agency raised its price target on the company's stock from $35 to $36. On Monday, MAKO lost 10.9% of its value to finish the day at $21.41. Its shares rebounded in today's pre-market trading, rising 8.59% to stand around $23.25.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetReiterationAnalyst RatingsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!